Ultragenyx Pharmaceutical (RARE)
NASDAQ:RARE
Holding RARE?
Track your performance easily

Ultragenyx Pharmaceutical (RARE) Similar Stocks

744 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Ultragenyx Pharmaceutical
$4.71B
-7.16
32.67%
16 Buy
1 Hold
0 Sell
Strong Buy
Allogene Therapeutics
$627.33M
-1.86
-1.83%
9 Buy
2 Hold
0 Sell
Strong Buy
Crispr Therapeutics AG
$4.31B
-15.60
-13.42%
8 Buy
6 Hold
2 Sell
Moderate Buy
Editas Medicine
$237.53M
-1.22
-63.39%
10 Buy
6 Hold
0 Sell
Moderate Buy
Intellia Therapeutics
$1.54B
-2.82
-47.68%
16 Buy
4 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
RARE
Ultragenyx Pharmaceutical
50.52
12.44
32.67%
ALLO
Allogene Therapeutics
3.22
-0.06
-1.83%
CRSP
Crispr Therapeutics AG
50.72
-7.86
-13.42%
EDIT
Editas Medicine
3.28
-5.68
-63.39%
NTLA
Intellia Therapeutics
16.06
-13.43
-45.54%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis